Impact of Smoke Free Public Places (Smoke Free Cabs) on Cab Drivers in Mumbai
Impact of Smoke Free Public Places (Smoke Free Cabs) on Cab Drivers in Mumbai, India
In addition to the passengers smoking inside the cab, the taxi drivers,are themselves addicted to smoking and/ or use of smokeless tobacco. Since tobacco is highly addictive, the cab drivers using tobacco need help in quitting. It is also necessary to raise the awareness of the cab drivers with respect to the hazards of tobacco and significance of the smoke free legislation.
It's been six years since the implementation of rules prohibiting smoking in public places and a re-look at the compliance to this regulation is necessary. The study will also help tobacco users to quit their habits. They will get screened for oral premalignant and malignant lesions.
Also, the cab drivers may pass on some effective messages regarding importance of keeping oneself away from tobacco, to the customers while commuting. In view of the above background, the current study is proposed to look at all these aspects.
The findings of the study will be certainly generating useful information with regards to lacunae in the existing system for appropriate implementation and for strengthening anti tobacco advocacy in our country.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
AIM and OBJECTIVES:
- To study the Knowledge, Attitudes and Practices (KAP) regarding tobacco and smoke free public places among cab drivers ferrying customers near Tata Memorial Hospital
- To study the impact of smoke free public places with specific reference to smoke free cabs (on various factors such as number of customers, customer practices, health status, self practices, compliance etc.)
- To understand their attitude towards smoke free cabs.
- To educate them regarding hazards of tobacco and the need for smoke free cabs.
- To invite the cab drivers using tobacco to avail the Preventive Oncology screening facilities and Tobacco cessation clinic at the Tata Memorial Hospital
- To evaluate the compliance for availing the services
- To study the post-intervention KAP regarding tobacco and smoke free public places
- To determine the rate of oral pre-cancers and tobacco cessation after one year follow-up.
Methodology:
Design: Single arm interventional study
Step 1: Around 400 cab drivers in Mumbai will be enrolled after explaining the programme and obtaining informed consent. They will be interviewed with the help of a well structured questionnaire to collect information about their Knowledge, Attitudes and Practices (KAP) regarding tobacco, their attitudes and experiences regarding smoke free public places with specific reference to smoke free cabs.
Step 2: The cab drivers will be given detailed health education regarding hazards of tobacco and the need for smoke free cabs. They will be invited to participate in oral cancer screening at the Preventive Oncology (PO) screening clinic.
Step 3: The cab drivers will be again interviewed with the help of a well structured questionnaire to collect information of their post-intervention KAP regarding tobacco and smoke free public places.
Step 4: The cab drivers using tobacco will be invited to participate in the tobacco cessation programme at the TCC and will receive three monthly follow-up for one year. Various tobacco cessation interventions in the form of one to one counseling, focus group discussions, role plays, games etc. will be used. In addition they will be engaged in conveying messages about tobacco control and refraining from tobacco habit, to the customers while commuting. This will also reinforce their own commitment towards tobacco cessation.
Variables to be estimated:
- the change in the baseline KAP
- the perceptions and attitude of cab drivers regarding implementation of smoke free cab policy.
- the results of oral cancer screening in the form of oral pre-cancers and cancers detected
- the success of tobacco cessation programme in the form of self reported quit rates at the end of one year
- reactions of the commuters and their own perceptions towards the no tobacco messages conveyed to the customers while traveling
Data Analysis:
Data entry will be done in the Department of Preventive Oncology, Tata Memorial Hospital using SPSS version 18. Checks for consistency, data safety and analysis will be carried out at regular intervals. Both descriptive and inferential statistics will be generated for describing variables under the study objectives.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Maharashtra
-
Mumbai, Maharashtra, India, 400012
- Gauravi A. Mishra
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- 400 Cab drivers ferrying customers near Tata Memorial Hospital on a regular basis
Exclusion Criteria:
- Any Cab drivers outside the category as mentioned in the proposal
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Selezione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Tobacco users: behavioural counseling
The cab drivers using tobacco will be invited to participate in the tobacco cessation programme at the TCC and will receive three monthly follow-up for one year.
Thus intervention will be in the form of behavioural therapy and pharmacotherapy (if required)
|
Various tobacco cessation interventions in the form of one to one counseling, focus group discussions, role plays, games etc. will be used in the tobacco users.
Pharmacotherapy will also be prescribed as per the need assessment consisting of: Nicotine Chewing Gums: Dose: 2 mg/4 mg, 10-15 pieces per day with maximum dose of 24 pieces/day depending on cravings.Total Duration: 12 weeks Duration of treatment: Higher dose for 4-6 weeks, with weaning till 2-3 months Nicotine Transdermal patches: Dose: 7 mg/10 mg/14 mg/21 mg -for 24-hours use. Total Duration: 12 weeks Duration of treatment: Higher strength patch for 2 weeks and depending on cravings will be gradually decreased till 4 weeks
Altri nomi:
|
|
Nessun intervento: Non Users
The cab drivers who are not using tobacco in any form will not receive any type of intervention
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Knowledge, Attitude & practice (change in the baseline KAP)
Lasso di tempo: 30 months
|
a) The
|
30 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Attitude regarding implementation of smoke free policy (perceptions and attitude of cab drivers)
Lasso di tempo: 30 months
|
b) The perceptions and attitude of cab drivers regarding implementation of smoke free cab policy.
|
30 months
|
|
Oral cancer detection by oral screening
Lasso di tempo: 30 months
|
c)The results of oral cancer screening in the form of oral pre-cancers and cancers detected
|
30 months
|
|
Quit rates (self reported quit rates)
Lasso di tempo: 30 months
|
d) The success of tobacco cessation programme in the form of self reported quit rates at the end of one year
|
30 months
|
|
Reactions towards no tobacco messages (Reactions of the commuters and their own perceptions)
Lasso di tempo: 30 months
|
e) Reactions of the commuters and their own perceptions towards the no tobacco messages conveyed to the customers while traveling
|
30 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Gauravi A Mishra, Assoc Prof, Tata Memorial Hospital, Mumbai
- Investigatore principale: Sharmila A Pimple, Professor, Tata Memorial Hospital, Mumbai
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- TMHPOCAB2015
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .